1. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?. Issue 1 (29th June 2007) Authors: Carulli, M T; Handler, C; Coghlan, J G; Black, C M; Denton, C P Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 1(2008) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗